Caligan Partners Lp Top Holdings and 13F Report (2024) About Caligan Partners LpInvestment ActivityCaligan Partners Lp has $520.17 million in total holdings as of June 30, 2024.Caligan Partners Lp owns shares of 17 different stocks, but just 7 companies or ETFs make up 80% of its holdings.Approximately 10.83% of the portfolio was purchased this quarter.About 9.26% of the portfolio was sold this quarter.This quarter, Caligan Partners Lp has purchased 16 new stocks and bought additional shares in 9 stocks.Caligan Partners Lp sold shares of 2 stocks and completely divested from 1 stock this quarter.Largest Holdings Verona Pharma PLC American Depositary Share $135,899,921Liquidia Technologies $101,161,394Exelixis $67,246,550Agios Pharmaceuticals $35,630,041Merus $34,558,147 Largest New Holdings this Quarter 81642T209 - SELLAS Life Sciences Group $5,037,000 Holding05153U107 - Aura Biosciences $1,252,000 Holding Largest Purchases this Quarter Merus 280,045 shares (about $14.73M)Agios Pharmaceuticals 369,978 shares (about $12.31M)Revolution Medicines 171,835 shares (about $6.32M)Rezolute 1,401,705 shares (about $6.25M)Evolus 610,816 shares (about $5.63M) Largest Sales this Quarter BioCryst Pharmaceuticals 2,468,761 shares (about $22.12M)Mineralys Therapeutics 132,315 shares (about $1.79M) Sector Allocation Over TimeMap of 500 Largest Holdings ofCaligan Partners Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorVRNAVerona Pharma PLC American Depositary Share$135,899,9210.0%1,436,87826.1%MedicalLQDALiquidia Technologies$101,161,394$3,738 ▲0.0%8,118,89219.4%MedicalEXELExelixis$67,246,5500.0%1,525,73012.9%MedicalAGIOAgios Pharmaceuticals$35,630,041$12,305,468 ▲52.8%1,071,2586.8%MedicalMRUSMerus$34,558,147$14,730,367 ▲74.3%656,9996.6%MedicalEOLSEvolus$30,779,544$5,625,615 ▲22.4%3,341,9705.9%MedicalMLYSMineralys Therapeutics$27,294,773$1,790,222 ▼-6.2%2,017,3525.2%MedicalRVMDRevolution Medicines$23,429,160$6,321,810 ▲37.0%636,8354.5%MedicalANIKAnika Therapeutics$15,183,6750.0%1,435,1302.9%MedicalABIVAX SA$12,809,160$3,100,400 ▲31.9%1,674,4002.5%SPONSORED ADSYMABY-mAbs Therapeutics$10,565,1670.0%2,342,6092.0%MedicalRZLTRezolute$6,881,842$6,251,604 ▲991.9%1,543,0141.3%MedicalBCRXBioCryst Pharmaceuticals$5,724,616$22,120,100 ▼-79.4%638,9081.1%MedicalSLSSELLAS Life Sciences Group$5,037,000$5,037,000 ▲New Holding2,300,0001.0%MedicalVRCAVerrica Pharmaceuticals$4,897,657$130,492 ▲2.7%9,239,1190.9%MedicalTYRATyra Biosciences$1,817,822$1,578,572 ▲659.8%189,9500.3%MedicalAURAAura Biosciences$1,252,000$1,252,000 ▲New Holding200,0000.2%MedicalSAGESage Therapeutics$0$24,267,677 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access